1Crea F,Biasueei LM, Buffon A, et al. Role of inflammation in the pathogenesis of unstable coronary artery disease.Am J Cardiol, 1997, 80: 10E- 16E.
2Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation, 2002, 106(8) : 913- 919.
11 Alexander R W.Inflammation and coronary artery disease.N Engl J Med,1994,331:468～469
22 Berk B C,Weintraub W S,Alexander R W.Elevation of C-reactive protein in “active” coronary disease.Am J Cardiol,1990,65:168～172
33 DeBeer F C,Hird C R,Fox K M,et al.Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction.Br Heart J,1982,47:239～243
44 Frits H,Simon G P,Stephen D M,et al.Production of C-reactine protein and risk of coronary events in stable and unstable angina.Lancet,1997,349:462～466
5Held C,Hjemdahl P,Rehnqvist N,et al.Haemostatic markers,inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm(APSIS):a comparison with healthy controls.J Intern Med,1997,241:59
6Gardenan A,Lohre J,Katz N,et al.The 4G/4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosis in patients at high risk for this disease.Thromb Haemost,1999,82:1121
7Stengard JH,Weiss KM,Sing CF,et al.An ecological study of association between coronary heart disease mortality in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E.Hum Genet,1998,103:234
8Maat M PM,Green F,Knijffp,et al.Factor Ⅶ polymorphisms in populations with different risks of cardiovascular disease.Arterioscler Thromb Vasc Biol,1997,17:1918
9Katsuya T,Koike G,Yee TW,et al.Association of angiotensinogen T235 variant increased risk of coronary heart disease.Lancet,1995 Jun 24,345(8965):1600
5Choudhary N,Ahlawat RS.Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy:new evidence linking inflammation,glycemic control,and microalhuminuria[J].Iran J Kidney Dis,2008,2(2):72-79.
6Haidari M,Javadi E,Sadeghi B,et al.Evaluation of C-reactive protein,a sensitive marker of inflammation,as a risk factor for stable coronary artery disease[J].Clin Biochem,2001,34(4):309-315.
7Ahluwalia TS,Khullar M,Ahuja M,et al.Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diatetes among Asian Indians[J].PLoS ONE,2009,4(4):1-10.
8Mojahedi MJ,Bonakdaran S,Hami M,et al.Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 Diabetes melltus[J].Iran J Kidney Dis,2009,3(1):12-16.
9Kang ES,Kim HJ,Ahn CW,et al.Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes[J].Diabetes Res Clin Pract,2005,69(2):151-159.
10Gersh BJ, Braunwald E, Rutherford JD. Chronic coronary artery disease.//Brounwald E. Heart disease:ATextbook of cardiovascular Medcine[M]. 5th. Philadelphia: saunders, 1999 : 1239-1365.
